URGN position history
The shares of Urogen Pharma (URGN) that FARALLON CAPITAL MANAGEMENT, L.L.C. reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2025 Q3: 22,000 shares, $439K, <0.01% of portfolio, New
- 2025 Q4: 11,000 shares, $258K, <0.01% of portfolio, Reduce −50.0%
- 2026 Q1: 11,000 shares, $198K, <0.01% of portfolio
- 2026 Q2: not held, Exit
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|